Medytox Solutions Inc. (MMMS) Financials Oct 29, 2014, 12:00 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Medytox Solutions Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 11,082 77,591 3.99M 21.08M 52.52M
Cost of Goods Sold (COGS) incl. D&A 1,500 46,637 500,336 2.98M 9.98M
COGS excluding D&A 0 43,137 481,891 2.91M 9.57M
Depreciation & Amortization Expense 1,500 3,500 18,445 65,648 407,971
Depreciation 1,500 3,500 - 65,648 407,971
Amortization of Intangibles - - - - 0
Gross Income 9,582 30,954 3.49M 18.1M 42.54M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 49,418 253,252 2.88M 14.57M 27.07M
Research & Development 0 0 - 0 -
Other SG&A 49,418 253,252 2.88M 14.57M 27.07M
Other Operating Expense 10,626 102,952 0 0 0
Unusual Expense 0 0 18,586 (348,315) 1.15M
EBIT after Unusual Expense 0 0 (18,586) 348,315 (1.15M)
Non Operating Income/Expense 0 0 0 2,675 (27,024)
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 4,038 1,791 174,973 653,588 474,649
Gross Interest Expense 4,038 1,791 174,973 653,588 474,649
Interest Capitalized 0 0 0 0 0
Pretax Income (54,500) (327,041) 414,595 3.23M 13.83M
Income Tax 0 0 (172,200) 481,400 5.57M
Income Tax - Current Domestic 0 0 - 1.88M 6.86M
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - (1.4M) (1.29M)
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 - 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 (397,918) 0
Consolidated Net Income (54,500) (327,041) 586,795 2.35M 8.26M
Minority Interest Expense 0 0 494,094 0 0
Net Income (54,500) (327,041) 92,701 2.35M 8.26M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (54,500) (327,041) 92,701 2.35M 8.26M
Preferred Dividends 0 0 0 50,000 2.6M
Net Income Available to Common (54,500) (327,041) 92,701 2.3M 5.66M
EPS (Basic) 0.00 (0.01) 0.00 0.07 0.19
Basic Shares Outstanding 41.35M 41.35M 33.32M 30.8M 29.65M
EPS (Diluted) 0.00 (0.01) 0.00 0.07 0.19
Diluted Shares Outstanding 41.35M 41.35M 33.32M 30.8M 29.65M
EBITDA (48,962) (321,750) 626,599 3.6M 15.88M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Medytox Solutions Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 11,082 77,591 3.99M 21.08M 52.52M
Cost of Goods Sold (COGS) incl. D&A 1,500 46,637 500,336 2.98M 9.98M
COGS excluding D&A 0 43,137 481,891 2.91M 9.57M
Depreciation & Amortization Expense 1,500 3,500 18,445 65,648 407,971
Depreciation 1,500 3,500 - 65,648 407,971
Amortization of Intangibles - - - - 0
Gross Income 9,582 30,954 3.49M 18.1M 42.54M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 49,418 253,252 2.88M 14.57M 27.07M
Research & Development 0 0 - 0 -
Other SG&A 49,418 253,252 2.88M 14.57M 27.07M
Other Operating Expense 10,626 102,952 0 0 0
Unusual Expense 0 0 18,586 (348,315) 1.15M
EBIT after Unusual Expense 0 0 (18,586) 348,315 (1.15M)
Non Operating Income/Expense 0 0 0 2,675 (27,024)
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 4,038 1,791 174,973 653,588 474,649
Gross Interest Expense 4,038 1,791 174,973 653,588 474,649
Interest Capitalized 0 0 0 0 0
Pretax Income (54,500) (327,041) 414,595 3.23M 13.83M
Income Tax 0 0 (172,200) 481,400 5.57M
Income Tax - Current Domestic 0 0 - 1.88M 6.86M
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - (1.4M) (1.29M)
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 - 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 (397,918) 0
Consolidated Net Income (54,500) (327,041) 586,795 2.35M 8.26M
Minority Interest Expense 0 0 494,094 0 0
Net Income (54,500) (327,041) 92,701 2.35M 8.26M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (54,500) (327,041) 92,701 2.35M 8.26M
Preferred Dividends 0 0 0 50,000 2.6M
Net Income Available to Common (54,500) (327,041) 92,701 2.3M 5.66M
EPS (Basic) 0.00 (0.01) 0.00 0.07 0.19
Basic Shares Outstanding 41.35M 41.35M 33.32M 30.8M 29.65M
EPS (Diluted) 0.00 (0.01) 0.00 0.07 0.19
Diluted Shares Outstanding 41.35M 41.35M 33.32M 30.8M 29.65M
EBITDA (48,962) (321,750) 626,599 3.6M 15.88M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
